These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22387453)

  • 21. Stability of Borrelia burgdorferi outer surface protein C under immune selection pressure.
    Hodzic E; Feng S; Barthold SW
    J Infect Dis; 2000 Feb; 181(2):750-3. PubMed ID: 10669369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ; Berardi VP; Persing DH; Sigal LH
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminal disulfide-bridging of Borrelia outer surface protein C increases its diagnostic and vaccine potentials.
    Probst C; Ott A; Scheper T; Meyer W; Stöcker W; Komorowski L
    Ticks Tick Borne Dis; 2012 Feb; 3(1):1-7. PubMed ID: 22309852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a unique borreliacidal epitope on the outer surface protein C of Borrelia burgdorferi.
    Yang X; Li Y; Dunn JJ; Luft BJ
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):64-74. PubMed ID: 16965353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disulfide-mediated oligomer formation in Borrelia burgdorferi outer surface protein C, a critical virulence factor and potential Lyme disease vaccine candidate.
    Earnhart CG; Rhodes DV; Marconi RT
    Clin Vaccine Immunol; 2011 Jun; 18(6):901-6. PubMed ID: 21525304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved laboratory diagnostics of Lyme neuroborreliosis in children by detection of antibodies to new antigens in cerebrospinal fluid.
    Skogman BH; Croner S; Forsberg P; Ernerudh J; Lahdenne P; Sillanpää H; Seppälä I
    Pediatr Infect Dis J; 2008 Jul; 27(7):605-12. PubMed ID: 18536620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula.
    Nassal M; Skamel C; Kratz PA; Wallich R; Stehle T; Simon MM
    Eur J Immunol; 2005 Feb; 35(2):655-65. PubMed ID: 15668917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.
    Ledue TB; Collins MF; Young J; Schriefer ME
    Clin Vaccine Immunol; 2008 Dec; 15(12):1796-804. PubMed ID: 18945880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of an ospC operator critical for immune evasion of Borrelia burgdorferi.
    Xu Q; McShan K; Liang FT
    Mol Microbiol; 2007 Apr; 64(1):220-31. PubMed ID: 17376084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands.
    Pal U; Yang X; Chen M; Bockenstedt LK; Anderson JF; Flavell RA; Norgard MV; Fikrig E
    J Clin Invest; 2004 Jan; 113(2):220-30. PubMed ID: 14722614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Borrelia burgdorferi outer surface protein (osp) B expression independent of ospA.
    Liang FT; Caimano MJ; Radolf JD; Fikrig E
    Microb Pathog; 2004 Jul; 37(1):35-40. PubMed ID: 15194158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and optimization of OspC chimeritope vaccinogens for Lyme disease.
    Izac JR; O'Bier NS; Oliver LD; Camire AC; Earnhart CG; LeBlanc Rhodes DV; Young BF; Parnham SR; Davies C; Marconi RT
    Vaccine; 2020 Feb; 38(8):1915-1924. PubMed ID: 31959423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development.
    Buckles EL; Earnhart CG; Marconi RT
    Clin Vaccine Immunol; 2006 Oct; 13(10):1162-5. PubMed ID: 17028218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains.
    Earnhart CG; Buckles EL; Marconi RT
    Vaccine; 2007 Jan; 25(3):466-80. PubMed ID: 16996663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eliminating Factor H-Binding Activity of
    Marcinkiewicz AL; Lieknina I; Kotelovica S; Yang X; Kraiczy P; Pal U; Lin YP; Tars K
    Front Immunol; 2018; 9():181. PubMed ID: 29472926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term intrathecal infusion of outer surface protein C from Borrelia burgdorferi causes axonal damage.
    Tauber SC; Ribes S; Ebert S; Heinz T; Fingerle V; Bunkowski S; Kugelstadt D; Spreer A; Jahn O; Eiffert H; Nau R
    J Neuropathol Exp Neurol; 2011 Sep; 70(9):748-57. PubMed ID: 21865883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.
    Jobe DA; Lovrich SD; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):573-8. PubMed ID: 12853388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences.
    Earnhart CG; Marconi RT
    Hum Vaccin; 2007; 3(6):281-9. PubMed ID: 17921702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development.
    Oliver LD; Earnhart CG; Virginia-Rhodes D; Theisen M; Marconi RT
    Vet J; 2016 Dec; 218():27-33. PubMed ID: 27938705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease.
    Hassan WS; Giaretta PR; Rech R; Ollivault-Shiflett M; Esteve-Gasent MD
    Vaccine; 2019 Sep; 37(37):5596-5606. PubMed ID: 31387750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.